The 2023 Good Tech Awards Toasting a year of breakthroughs (and a few breakdowns) in Silicon Valley and beyond.
New Sickle Cell Therapies Will Be Out of Reach Where They Are Needed Most There is no clear path for African patients to get access to the treatments, which have multimillion-dollar price tags and are highly complex to manufacture and deliver.
F.D.A. Approves 2 Sickle Cell Treatments, One Using CRISPR Gene Editing People with the genetic disease have new opportunities to eliminate their symptoms, but the treatments come with obstacles that limit their reach.
CAR-T, Lifesaving Cancer Treatment, May Sometimes Cause Cancer, FDA Says The agency is looking into reports that some patients developed new blood cancers after receiving CAR-T treatments.
An A.I. Pin Drops + YouTube’s Take on Deepfakes + a Lab-Grown Thanksgiving The companies changing our phones, our media and our meat.